Menu
GeneBe

rs796052790

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM1BP4_ModerateBS2

The NM_001184880.2(PCDH19):ā€‹c.224A>Gā€‹(p.Asn75Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000497 in 1,207,697 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.000036 ( 0 hom., 2 hem., cov: 24)
Exomes š‘“: 0.0000018 ( 0 hom. 1 hem. )

Consequence

PCDH19
NM_001184880.2 missense

Scores

5
11

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4B:1

Conservation

PhyloP100: 2.62
Variant links:
Genes affected
PCDH19 (HGNC:14270): (protocadherin 19) The protein encoded by this gene is a member of the delta-2 protocadherin subclass of the cadherin superfamily. The encoded protein is thought to be a calcium-dependent cell-adhesion protein that is primarily expressed in the brain. Mutations in this gene on human chromosome X are associated with sporadic infantile epileptic encephalopathy and to a female-restricted form of epilepsy (EFMR; also known as PCDH19RE). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

PM1
In a domain Cadherin 1 (size 107) in uniprot entity PCD19_HUMAN there are 24 pathogenic changes around while only 1 benign (96%) in NM_001184880.2
BP4
Computational evidence support a benign effect (MetaRNN=0.21575347).
BS2
High Hemizygotes in GnomAd4 at 2 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PCDH19NM_001184880.2 linkuse as main transcriptc.224A>G p.Asn75Ser missense_variant 1/6 ENST00000373034.8
PCDH19NM_001105243.2 linkuse as main transcriptc.224A>G p.Asn75Ser missense_variant 1/5
PCDH19NM_020766.3 linkuse as main transcriptc.224A>G p.Asn75Ser missense_variant 1/5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PCDH19ENST00000373034.8 linkuse as main transcriptc.224A>G p.Asn75Ser missense_variant 1/61 NM_001184880.2 A1Q8TAB3-1
PCDH19ENST00000255531.8 linkuse as main transcriptc.224A>G p.Asn75Ser missense_variant 1/51 P5Q8TAB3-2
PCDH19ENST00000420881.6 linkuse as main transcriptc.224A>G p.Asn75Ser missense_variant 1/51 A1Q8TAB3-3

Frequencies

GnomAD3 genomes
AF:
0.0000360
AC:
4
AN:
110993
Hom.:
0
Cov.:
24
AF XY:
0.0000602
AC XY:
2
AN XY:
33213
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000757
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000556
AC:
1
AN:
179728
Hom.:
0
AF XY:
0.0000151
AC XY:
1
AN XY:
66020
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000526
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000182
AC:
2
AN:
1096704
Hom.:
0
Cov.:
32
AF XY:
0.00000276
AC XY:
1
AN XY:
362332
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000238
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000360
AC:
4
AN:
110993
Hom.:
0
Cov.:
24
AF XY:
0.0000602
AC XY:
2
AN XY:
33213
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000757
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000227

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4Benign:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy, 9 Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 31, 2018- -
Uncertain significance, criteria provided, single submitterclinical testingInvitaeOct 05, 2023This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 75 of the PCDH19 protein (p.Asn75Ser). This variant is present in population databases (rs796052790, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with PCDH19-related conditions. ClinVar contains an entry for this variant (Variation ID: 206292). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PCDH19 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoJan 09, 2020DNA sequence analysis of the PCDH19 gene demonstrated a sequence change, c.224A>G, in exon 1 that results in an amino acid change, p.Asn75Ser. This sequence change does not appear to have been previously described in patients with PCDH19-related disorders. This particular sequence change has been described in the gnomAD database in two individuals in the hemizygous state which corresponds to a population frequency of 0.00099% (dbSNP rs796052790). The p.Asn75Ser change affects a moderately conserved amino acid residue located in a domain of the PCDH19 protein that is known to be functional. The p.Asn75Ser substitution appears to be benign using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). Due to these contrasting evidences and the lack of functional studies, the clinical significance of the p.Asn75Ser change remains unknown at this time. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGeneDxAug 16, 2019The majority of missense variants in this gene are considered pathogenic (Stenson et al., 2014); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge -
Neurodevelopmental disorder with epilepsy Benign:1
Benign, no assertion criteria providedresearchNeurogenetics Research Program, University of AdelaideDec 20, 2019- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.88
CADD
Benign
19
DANN
Benign
0.96
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.89
D;D;D
M_CAP
Uncertain
0.093
D
MetaRNN
Benign
0.22
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.81
L;L;L
MutationTaster
Benign
0.91
D;D;D
PrimateAI
Uncertain
0.62
T
PROVEAN
Uncertain
-2.7
D;D;D
REVEL
Benign
0.10
Sift
Benign
0.14
T;T;T
Sift4G
Benign
0.28
T;T;T
Polyphen
0.0070
.;B;B
Vest4
0.22
MutPred
0.65
Gain of disorder (P = 0.034);Gain of disorder (P = 0.034);Gain of disorder (P = 0.034);
MVP
0.56
MPC
0.96
ClinPred
0.13
T
GERP RS
5.7
Varity_R
0.37
gMVP
0.22

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs796052790; hg19: chrX-99663372; API